Matthew Allen Walker - Aug 11, 2022 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC (GRNA)

Role
Director, 10%+ Owner
Signature
/s/ David Kennedy, Attorney-in-fact for Matthew Allen Walker
Stock symbol
GRNA
Transactions as of
Aug 11, 2022
Transactions value $
$25,249,998
Form type
4
Date filed
8/15/2022, 05:03 PM
Previous filing
Aug 8, 2022
Next filing
Jul 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRNA Common Stock Purchase $250K +63.8K $3.92* 63.8K Aug 11, 2022 Direct F1
transaction GRNA Common Stock Purchase $25M +6.38M +40.25% $3.92* 22.2M Aug 11, 2022 by Builders Vision, LLC F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 63,775 shares of Common Stock issued pursuant to a subscription agreement entered into between the Issuer and Matthew Allen Walker.
F2 Includes 6,377,551 shares of Common Stock issued pursuant to a subscription agreement entered into between the Issuer and S2G Builders Food & Agriculture Fund III, LP ("Fund III").
F3 Total number of shares beneficially owned by the Reporting Person includes: (i) 11,551,245 shares held by Fund III; (ii) 2,087,043 shares held by S2G Ventures Fund I, L.P. ("Fund I"); and (iiii) 8,582,284 shares held by S2G Ventures Fund II, L.P. ("Fund II" and, together with Fund I, and Fund III, the "S2G Funds"). Builders Vision, LLC is the Manager of Fund I and Fund II, and the General Partner of Fund III, and has power to vote or direct the voting of shares held by the S2G Funds. The General Partners of Fund I and Fund II are S2G Ventures, LLC and S2G Ventures II, LLC, respectively.
F4 (Continued) Mr. Walker, a director of the Issuer, is a Managing Director of Builders Vision, LLC, the impact platform founded by Lukas T. Walton, which includes S2G Ventures. By virtue of the foregoing, S2G Ventures, LLC and S2G Ventures II, LLC, Mr. Walker and Mr. Walton may be deemed to indirectly beneficially own (as defined in Rule 13d-3 of the Exchange Act) the shares of Common Stock held by the S2G Funds. Mr. Walker and Mr. Walton each disclaims beneficial ownership of these shares of Common Stock except to the extent of any pecuniary interest therein.